跳至主要内容
临床试验/NCT03456752
NCT03456752已完成2 期

The Impact of Perioperative Dexamethasone on Postoperative Outcome in Inflammatory Bowel Diseases.

Jinling Hospital, China1 个研究点 分布在 1 个国家目标入组 302 人开始时间: 2018年6月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
302
试验地点
1
主要终点
Prolonged ileus

研究概览

简要总结

The objective of this RCT is to determine the efficacy of a single preoperative dose of Dexamethasone for accelerating the recovery and reducing the incidence of postoperative complications in adult patients undergoing intestinal resection for inflammatory bowel disease.

详细描述

Patients undergoing surgery for IBD is associated with increased inflammatory response and incidence of prolonged ileus after surgery compared to other colorectal disease such as CRC. Previous studies have revealed that preoperative administration of glucocorticosteroids(GCs) decreased complications and length of postoperative length of hospital after major abdominal surgery as a likely consequence of attenuating the postsurgical inflammatory response. Also, a single dose of GCs did not increase complications in colorectal surgery. The aim of the study is to examine whether a single dose of dexamethasone prior to induction of anesthesia could promote the recovery of patients and reduce the incidence of prolonged ileus after surgery for IBD

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients undergoing elective open and laparoscopic small and large bowel operations for IBD, including Crohn's Disease(CD) and Ulcerative Colitis (UC).

排除标准

  • Diabetes or hyperglycemia
  • Active gastric ulceration confirmed endoscopically
  • Presence of ongoing infection (such as IAS) or infective chronic diseases
  • Currently receiving systemic therapy with glucocorticoids with prednisolone >=20mg for over 6 weeks within 30 days prior to surgery.
  • Emergent surgery
  • Acute angle glaucoma
  • Under 18 years of age
  • Known adverse reaction to dexamethasone
  • Extensive adhesiolysis
  • Carcinogenesis of intestinal tract

研究组 & 干预措施

Dexamethasone

Experimental

Dexamethasone 8mg intravenously prior to anesthesia induction

干预措施: Dexamethasone (Drug)

Control

Placebo Comparator

Normal Saline 1.6ml intravenously prior to anesthesia induction

干预措施: Normal saline (Drug)

结局指标

主要结局

Prolonged ileus

时间窗: Day 30

Prolonged POI was defined as if two or more of the following five criteria are met on day 4 postoperatively: nausea or vomiting; inability to tolerate an oral diet over last 24 h; absence of flatus over last 24 h; abdominal distension; and radiologic confirmation.

次要结局

  • Postoperative pain on POD 1, 3, and 5(up to 1 week)
  • PONV(Postoperative nausea and vomiting) and additional antiemetics given within 24hr after surgery(24hr)
  • Blood WBC levels, preoperative and on postoperative 1,3 and 5(Day 30)
  • Blood neutrophil percentage, preoperative and on postoperative 1,3 and 5(Day 30)
  • Serum C-reactive protein (CRP) level, preopperative and on postoperative 1,3 and 5(Day 30)
  • Serum procalcitonin (PCT) level, preopperative and on postoperative 1,3 and 5(Day 30)
  • Postoperative fagitue score on POD 1, 3, and 5(up to 1 week)
  • GI-2 recovery(Day 30)
  • Serum Interleukin-6 (IL-6) level, preopperative and on postoperative 1,3 and 5(Day 30)
  • Body composition, preoperative and on POD 1(Day 30)
  • Postoperative length of stay(Day 90)
  • Postoperative morbidity(Day 30)
  • Postoperative surgical site infections (SSIs)(Day 30)
  • Overall cost of treatment(up to 1 year)

研究者

发起方
Jinling Hospital, China
申办方类型
Other
责任方
Principal Investigator
主要研究者

Jianfeng Gong

Associate Professor

Jinling Hospital, China

研究点 (1)

Loading locations...

相似试验

Perioperative Dexamethasone on Postoperative Outcome... | 临床试验